The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
about
Synthesis, characterization and cytotoxicity studies of palladium(II)-proflavine complexesIn vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cellsNovel metals and metal complexes as platforms for cancer therapyTargeting and delivery of platinum-based anticancer drugs.Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review.Synthesis, characterization, DNA and HSA binding studies of isomeric Pd (II) antitumor complexes using spectrophotometry techniques.A novel oxaliplatin derivative, Ht-2, triggers mitochondrion-dependent apoptosis in human colon cancer cells.cis-[Pt(II) (1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a water-soluble, oxalate-free and stable analogue of oxaliplatin: synthesis, characterization, and biological evaluations.Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine.Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.Platinum-oxazoline complexes as anti-cancer agents: syntheses, characterisation and initial biological studiesNovel Palladium(II) and Platinum(II) Complexes with a Fluoropiperazinyl Based Ligand Exhibiting High Cytotoxicity and Anticancer ActivityIn Vitro
P2860
Q34330382-0D992E0B-61F2-4C44-8737-08FD9D8BBE8CQ35216231-681C24DC-D19A-425C-806D-0273932058D5Q36890460-6EDF4BB9-500C-4157-AF1A-6955DC4AED10Q37137649-182CDAEE-ECBA-4AD8-8927-6904EAE6EA47Q38050063-AC07D30B-E06E-421E-9634-B257DEC208B2Q38547474-51C2B61C-2BA4-425C-A155-40ED116A8A20Q38706344-365B2B87-5C2E-42E4-8C75-3BAC4A718E8EQ38948725-109DD216-C20C-4282-A2E7-FE4D31933F14Q39130757-80D3CDF1-2F95-4D1D-A703-5ADA8205B84CQ39400663-844A8ECE-D2F5-4E87-AFDD-E7E24D31D8A9Q39404847-95ADE4C6-604A-4A98-AD4C-AC5270B5550DQ39465410-0202B51B-3352-4BD2-8F7A-ACD0AEC9D76FQ39611155-3204BFB2-B2DB-4157-B3ED-D1680CDFEC40Q39695089-545AF0F2-2487-444A-B67A-81AD079EF37AQ46569102-0935A1C7-BB5D-4376-AD03-02F5017AE699Q53450886-5D06F56B-028D-41FE-A896-B9460546C262Q56434429-AEED8567-0D70-4B5A-8079-1D5D9CE537CAQ59125697-DCC7275E-A89B-4E9C-A3B4-99BDE8028276
P2860
The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The rational design of antican ...... ructure-activity relationship.
@en
The rational design of antican ...... ructure-activity relationship.
@nl
type
label
The rational design of antican ...... ructure-activity relationship.
@en
The rational design of antican ...... ructure-activity relationship.
@nl
prefLabel
The rational design of antican ...... ructure-activity relationship.
@en
The rational design of antican ...... ructure-activity relationship.
@nl
P1476
The rational design of antican ...... ructure-activity relationship.
@en
P2093
Angel M Montaña
Consuelo Batalla
P304
P356
10.2174/092986709788453087
P577
2009-01-01T00:00:00Z